PATENT CLAIM ANALYSIS

Application Number: 16040244
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["424", "134100"]

Abstract:
The invention provides antibodies, antibody drug conjugates, antibody-based fragments or antibody fragments (antigen-binding fragments), as well as antibody drug conjugates (ADCs) and chimeric antigen receptors (CARs), that specifically recognize human ROR1 and related compositions. Also provided in the invention are methods of using such antibodies in various diagnostic and therapeutic applications.

Claim (Index 7):
A pharmaceutical composition comprising (1) a therapeutically effective amount of the antibody, antibody-based binding protein or antibody fragment of  claim 1  and (2) a pharmaceutically acceptable carrier.

Metadata:
- Claim Count in Document: 6.0
- Percentile: 95.0
- Lexical Diversity: 1.46512
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13990977', '14940961', '16027967', '15988659', '14203997']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7959460117532945
- 35 USC 102 Novelty (BERT): 0.5335657708315373
- Combined Prediction Score: 0.7697079876611188
- Mean Citation Score: 362.485876
- Max Citation Score: 381.50797
- Similarity Product: 291.78732826103686

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test